Jpmorgan Chase & CO Globus Medical Inc Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Globus Medical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,628,382 shares of GMED stock, worth $161 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,628,382
Previous 2,804,330
6.27%
Holding current value
$161 Million
Previous $232 Million
17.05%
% of portfolio
0.02%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding GMED
# of Institutions
532Shares Held
113MCall Options Held
489KPut Options Held
32.4K-
Vanguard Group Inc Valley Forge, PA10.7MShares$658 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$635 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X08.21MShares$504 Million0.25% of portfolio
-
Burgundy Asset Management Ltd. Toronto, A63.48MShares$214 Million2.09% of portfolio
-
State Street Corp Boston, MA3.47MShares$213 Million0.01% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $4.73B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...